Professional Documents
Culture Documents
Report On in Plant Training Final
Report On in Plant Training Final
Duration of Training
06th February 2024 To 17th February 2024
Submitted To
Dr. Md. Golam Moula
DGM, Head of HR and Administration
BIOPHARMA Limited
Submitted by
Sl. No. Name of Trainee Reg. No. Institute
01 Habiba Rahman 17203032 University of Asia Pacific
02 Anindita Mitra Hridy 19203025 University of Asia Pacific
03 Khandakar Afia Amina 19203038 University of Asia Pacific
04 Nishkriti Sarker 19203043 University of Asia Pacific
05 Khairatun Hesan 19203044 University of Asia Pacific
06 Fatema Tuzz johura Mumu 191-29-1460 Daffodil International University
07 Sanjida Rahman 191-29-1447 Daffodil International University
Date of submission
March 13, 2024
Preface
We are the students of the Department of Pharmacy of University of Asia Pacific and Daffodil
International University had got the opportunity to complete my training session in Biopharma
Limited. Pharmacists are the most important human resources for pharmaceutical industries.
In-plant training in any pharmaceutical industry is considered as a part of B. Pharm (Hon’s)
course because practical experience makes a man or women perfect to his or her respective
profession. Realizing this fact to achieve such practical knowledge.
We hope Biopharma Limited will be able to achieve its mission and vision.
1
Acknowledgement
All praises are for almighty Allah who has given us the ability to complete our training session
and opportunity to study in this subject.
It is our great pleasure and proud privilege to express our deep sense of gratitude to the authority
of University of Asia Pacific and Daffodil International University for providing us with the
training facility in the factory. In this context we would like to express our gratitude to all the
workers too for their excellent support to us during this period of in plant training.
Thank You
Habiba Rahman
Anindita Mitra Hridy
Khandakar Afia Amina
Nishkriti Sarker
Khairatun Hesan
Fatema Tuzz johura Mumu
Sanjida Rahman
2
Executive Summary
There are several industries that are growing very fast in Bangladesh. Among them
pharmaceutical sector is one. For the last few years Bangladesh has earned a lot of foreign
exchange by exporting drugs throughout the world. In addition, Bangladesh is now self-
dependent in this sector. To carry on this envelopment the drug act was first published in 1982.
The ultimate result of this set is that now-a-days Bangladesh is the most promising country
among the least developing countries in this sector.
BIOPHARMA Ltd. is very much faithful to the country in this purpose. BIOPHARMA Ltd,
started its operation in Bangladesh in 1999, has now I grown to become the nation’s one of the
leading pharmaceutical companies. BIOPHARMA manufactures a range of dosage forms
including tablets, capsules, dry syrup, syrup, suspension, powder for suspension, cream,
ointment etc.
Technology carries the promise of tomorrow. The benefits of technology belong to all of us
benefits of that create new opportunities and open doors to a better. The BIOPHARMA has
been designed in a way to ensure highest-possible quality at every stage of manufacturing and
quality control. World-class facilities are being employed in each and every step including
mixing, filling, labeling, batch and other procedures to ensure manufacturing of world class
products.
3
Special thanks to the following persons
Our deepest thanks to all section in charge, Officer, Supervisor, Workers in all department for
their respective cooperation and valuable guidance which help us to enrich us Pharmaceutical
Truly we felt an extreme happiness for getting a training opportunity in BPL and we are pleased
4
Objective of Our Internship
For the last four years, we went through several courses in pharmacy to complete our
graduation. We studied many topics and matters, but we would not see their implications in
departments.
5
Biopharma Limited at a glance
Biopharma Limited, one of the fast-growing pharmaceutical companies in Bangladesh,
has been manufacturing and marketing a wide range of pharmaceutical finished
products with strict standard of safety, quality and efficacy to ensure public healthcare
thought uncompromising scientific and professional approach since 1999. The
company has sailed its journey with the involvement of a group of physicians, inspired
with love for mankind, with innovative mission and global conception and ethical
practice in pharmaceutical sector of Bangladesh.
Biopharma Limited are now producing a wide range of Biological and pharmaceutical
products in different dosage forms and presentations including tablets, capsules, syrups,
suspensions, powder for suspensions, pediatric drops, sterile creams & ointments and
inject able preparations.
6
Contents
7
List of Abbreviation
Term Elaboration
IC Inventory Control
8
HR& Administration Department
HR and administration are concerned with managing business operations and, consequently,
with making and carrying out important choices. The universal process of effectively allocating
resources and people to steer operations towards shared goals and objectives is known as
administration.
In BIOPHARMA Ltd, administrative head is the factory’s Deputy Manager Operations
himself.
Administrative Functions:
This department's primary goal is to maintain the smooth operation of the plant by carrying out
the following duties:
➢ Recruitment of people with the necessary training and expertise to occupy all positions
that impact quality. Various standards are taken into account depending on the role.
➢ Help new hires finish their onboarding tasks and make sure they are placed.
➢ To set up an orientation and induction-training programme for new hires. Each
employee is given an overview of the company's operations and each department after
joining.
➢ Assemble and oversee an internship programme for university students.
➢ Organise and update each employee's personal file once a month. The employee file is
updated with information such as confirmation of work augmentation, promotion,
transfer, and other letters.
➢ Oversee and track the monthly attendance of your staff. Job cards, daily absentee
reports, and monthly attendance summaries, among other things.
➢ Monitor & update leaves of plant employees. Each employees has a leave file which
integrated the all kinds of leaves.
➢ Inform management and staff about the company's personnel policies and procedures.
➢ Coordinate & monitor performance appraisal of plants employees annually.
➢ Determine the staff's training requirements in light of cGMP and other work-related
concerns.
➢ Deals with matters pertaining to the workplace, such as protecting workers' rights and
negotiating with unions.
➢ Make sure that labour rules that affect factory workers are properly implemented.
➢ Disciplinary measures, including as penalty, suspension, and termination.
➢ Maintain a positive labor-management relationship to facilitate efficient output.
➢ Maintain communicating with government regulatory agencies.
➢ Ensure safety of all employees & company assets
9
Quality Assurance Department
Assigned person,
Sheikh Arif Hasan (Assistant Manager, QA)
10
Introduction:
In pharmaceutical market the few companies that give quality product, Biopharma is one of
them. Now a days manufacturing of quality product is quite difficult. From the raw material to
the finished product in each and every step quality operation department plays a very important
role.
Quality Assurance (QA), is the activity of providing evidence needed to establish quality in
work, and that activities that require good quality are being performed effectively all those
planned or systematic actions necessary to provide enough confidence that a product or service
will satisfy the given requirements for quality. QA introduces the rules—'fit for purpose' and
'do it right the first time'. It can be achieved by introducing appropriate standard operating
procedures (SOPs) in-house.
Quality assurance is a wide ranging concept covering all matters that individually or
collectively influence the quality of a product.
QA = QC + GMP
The Quality Assurance Department is vital for a pharmaceutical industry since it controls and
assures the quality of the products starting from the raw materials.
Branch of QA:
11
Functions of Quality Assurance Department:
1) Vender evaluation
2) Raw Material Analysis
3) In Process Analysis
4) Packaging Material Analysis
5) Finished Goods Analysis
6) Calibration and validation of Laboratory Instruments
7) Fixation of Expiration Date (Stability test)
8) Process Validation
9) Product Complained analysis
10) Investigation of Out of specification
11) GMP Audit
12) New source approval
13) Raw material validation
14) Microbiological Analysis
15) Development of new SOP (Standard Operating Procedure) for analysis.
A. Granulation
1. Appearance
2. LOD.
B. Compression:
1. Appearance.
2. Average wt.
3. Uniformity of wt.
4. Friability test.
12
5. DT test.
6. Diameter.
7. Thickness.
8. Temperature.
9. Relative humidity.
C. Coating:
1. Appearance.
2. Average wt.
3. Uniformity of wt.
4. Temperature.
5. Relative humidity.
D. Packaging:
1. Batch No.
2. Mfg date.
3. Exp date.
4. Leak test.
5. Temperature.
6. Relative humidity.
2. CAPSULE-
A. Encapsulation:
1. Appearance.
2. Average wt.
3. Uniformity of wt.
4. Temperature.
5. Relative humidity.
6. DT test.
B. Packaging:
1. Batch No.
2. Mfg No.
3. Exp date.
4. Temperature.
5. Relative humidity.
1. Appearance.
2. LOD
3. Filling wt.
4. Temperature.
5. Relative humidity.
B. Packaging:
1. Batch No.
2. Mfg No.
13
3. Exp date.
4. Temperature.
5. Relative humidity.
A. Preparation:
1. Appearance.
2. LOD
3. Filling wt.
4. Temperature.
5. Relative humidity.
B. Packing:
1. Batch No.
2. Mfg No.
3. Exp date.
4. Temperature.
5. Relative humidity.
5. ORAL LIQUID:
A. Preparation:
1. Appearance.
2. PH.
3. Filling wt.
4. Temperature.
5. Relative humidity.
B. Packaging:
1. Batch No.
2. Mfg No.
3. Exp date.
6. VIALS:
A. Preparation:
1. Appearance.
2. Particle count.
3. Filling wt.
4. Temperature.
5. Relative humidity.
B. Packaging:
1. Batch No.
2. Mfg No.
3. Exp date.
7. AMPOULES:
A. Preparation:
1. Appearance.
2. Particle count.
3. Filling wt.
14
4. Temperature.
5. Relative humidity.
B. Packaging:
1. Batch No.
2. Mfg No.
3. Exp date.
One of the important responsibilities of Quality Assurance Department is the sampling of the
incoming materials. The flow chart of this process is given below-
Take MRN & go to the warehouse with sampling equipment & container
For validation, Validation protocol and Validation master plan are essential. Validation may
be beneficial for the manufacture in this way:
15
• It depends the under standing of process, decreases the risk processing.
• It decreases the risk of costs.
• It decreases the risk of cost.
• It decreases the regulatory non-compliance.
• A fully validated process may require less in-process control and end product
testing.
Process Validation:
Establishing documented evidence which provides a high degree of assurance that a specific
process will consistently produce a product meeting its predetermined specifications and
quality attribute. According to FDA process validation is two types:
1. Prospective process validation.
2. Retrospective process validation.
Equipment Validation:
An equipment validation program can be described in four sequential phases:
16
Installation qualification-Establishing confidence that the process equipment and ancillary
system are capable of consistently operating with in establishes limits and tolerance.
Operational qualification- Documented verification that the system or sub system performs a
intended over all anticipation operating range.
Process qualification- Establishing confidence that process is effective and reproducible.
Stability Study:
A study of the stability of pharmaceutical product is essential for three main reasons. Firstly it
is important from the point of view of the safety of patient Secondly consideration must be
given to the relevant legal requirements concerned with the identity, strength, purity, quality of
the drug. Finally such a study is important of prevent economic repercussions of marketing an
unstable product.
Stability study is done by two methods:
1. Accelerated storage test.
2. Storage test method.
Product Complaints:
A complaint from the market may indicate some sort of defect on the product, which may range
from a minor fault to one of serious consequence. Correct & prompt evaluation of the market
complaint is an important part of quality assurance function. Procedure needs to be establishing
to receive complaint & deal with them efficiently.
A complaint may originate from consumer, chemists, hospitals or wholesalers/warehouse. QA
Department the complaints through marketing. It is important that the complaint, investigation,
relevant corrective actions & reporting back to the marketing are quick. This will ensure
product quality as ell as establish a better consumer relation.
Product Recall:
A product recall is a process of withdrawing one or more batches or all of a certain product
from market distribution. A product recalls is institute following discovery of a quality defect
or if there is a report of serious adverse reaction of a drug product which may cause health risk.
Total withdrawal of a drug product from market distribution may result in suspension or
discontinuation of manufacturing of products.
17
Self-Inspection:
The purpose of self-inspection is to evaluate the manufacturer’s compliance with GMP in all
aspects of production & quality control. The self-inspection program should be designed to
detect any shortcoming in the implementation of GMP and recommend the necessary
corrective action. Self-inspection should perform routinely, and may be, in addition, performed
on special occasion, e.g. in the case of product recalls repeated rejections or when an inspection
by the health authorities is announced. The team responsible for self-inspection should consist
of personnel who can evaluate the implementation of GMP objectively; all recommendations
for corrective action should be implemented. The procedure for self-inspection should be
documented and there should be an effective follow-up program.
Self-Inspection Team:
Management should appoint a team of self-inspection consisting of at list three members who
are expert in their own field & familiar with GMP. The member of the team may be appointed
18
from inside or outside the company. Each member should be independent in performing the
inspection & evaluation.
Self-Inspection Report:
A report should be made at the completion of self-inspection. The report should included
following things:
• Self-inspection report.
• Evaluation & conclusion.
• Recommended corrective action.
During our implant training we saw the following product in QA.
Aceta-Tab. Batch-658
Bacifen -Tab.
19
Product Development Department
Assigned person,
Md.Masudur Rahman (Assistant Manager, PD)
20
Activities Done by Pd
Formulation of New Product:
➢ Pre-formulation study of the active ingredients, which includes collecting all available
information of the active regarding its formulation its formulation , physical,
chemical, therapeutical, toxicological, microbiological (if necessary) data.
➢ Trail of the product in small scale that includes the entire manufacturing procedure.
➢ Comparative study on market sample for newly developing product and for existing
product.
➢ In case of INN products, raw material analysis and method development for
dissolution procedure.
➢ Stability & chemical analysis of the products those are included in compendia
(BP/USP) which often include HPLC analysis.
Documentation:
➢ BMR preparation of all new products.
➢ BMR of existing product dew to the batch size or other parameter.
➢ Stability data (accelerated and real time) preparation for export.
➢ Technical part of Recipe.
➢ Correction of Product Brief and Annexure.
➢ Process validation documentation.
21
Steps of the development of a new product:
Step-1: Product information from marketing department along with
………..necessary attributes such as
- Source
- Sample
- Q.C test (potency. LOD etc)
Step-2: Pre-formulation study of the active drug and excipients.
- Chemical activity.
- Function.
- Interaction.
- Boiling point.
- Contraindication.
- Moisture content etc.
22
- Theoretical yield
- Batch size
- Annexure etc.
Step-9: Transfer to production department commercial production.
Name of the Machinery:
➢ Universal motor drive.
➢ Fluid bed dryer.
➢ Tablet compression machine.
➢ Mixing M/C.
➢ Humidity chamber.
➢ Dry chamber.
➢ Friability tester.
➢ Roll compacter.
➢ Incubator.
➢ Light chamber.
➢ Disintegration tester.
➢ Unicoata-24.
➢ Rapid mixture granulator.
➢ Rotary tablet compression.
➢ Spectrophotometer.
➢ Multi mill.
During our implant training we saw the following product in PD.
Termider- Tab 250mg, from new source of raw material.
23
Production Department
Assigned person,
Md. Hafizur Rahman (Senior Deputy Manager, Production)
Md. Zahidul Islam Khan (Senior Assistant Manager, Production)
Md. Jobaer Alam (Assistant Manager, Production)
24
Tablet Processing Unit
Solid Section:
Solid dosage forms are among the most inexpensive, popular, and convenient methods of drug
delivery. They can be manufactured in a non-sterile environment, and the technology is well-
known after over a century of development. Because most pharmaceuticals are manufactured
in solid dosage forms, it is critical that the unit operations for their production be thoroughly
understood. This course covers the fundamentals of each discrete processing step (unit
operation) needed for the production and packaging of tablets and capsules, the most common
solid dosage forms.
Manufacturing Area
Tablet
A tablet is a solid formed by pressing or compacting active substances and excipients, which
are typically in powder form. Binders, glidants (flow aids), and lubricants are used to ensure
efficient tableting; disintegrants are used to break up the tablet in the digestive tract; sweeteners
or flavours are used to mask the taste of bad-tasting active ingredients; and pigments are used
to make uncoated tablets visually appealing. A polymer coating is typically applied to hide the
taste of the tablet's components, make the tablet smoother and easier to swallow, and increase
its resistance to the environment, thereby extending its shelf life.
25
A Typical Tablet Contains
Tablet Excipients:
Antiadherents:
Antiadherents are used to reduce the adhesion between the powder (granules) and the punch
faces and thus prevent sticking to tablet punches. The most commonly used is magnesium
stearate.
Binders:
Binders hold the ingredients in a tablet together.
Binders allow tablets and granules to be formed with the necessary mechanical strength while
also providing volume to low active doses tablets. Starches, sugars, cellulose or modified
cellulose (such as microcrystalline cellulose, hydroxypropyl cellulose), lactose, or sugar
alcohols such as xylitol, sorbitol, or maltitol are common binder materials.
Disintegrants:
Disintegrants expand and dissolve when wet causing the tablet to break apart in the digestive
tract, releasing the active ingredients for absorption. Disintegrant types include:
1. Water uptake facilitators
2. Tablet rupture promoters
They ensure that when the tablet is in contact with water, it rapidly breaks down into smaller
fragments, thereby facilitating dissolution. Examples of disintegrants include: crosslinked
polyvinyl, sodium starch glycolate, crosslinkedcrosslinked sodium (crosscarmellose).
Flavours:
Flavours can be used to mask unpleasant tasting active ingredients and improve the likelihood
that the patient will complete a course of medication. Flavourings may be natural (e.g. fruit
extract) or artificial.
26
Colours:
Colours are added to improve the appearance of a formulation. Colour consistency is important
as it allows easy identification of a medication.
Glidants:
Glidants are used to promote powder flow by reducing interparticle friction and cohesion.
These are used in combination with lubricants as they have no ability to reduce die wall friction.
Examples include colloidal silicon dioxide, talc, and magnesium carbonate.
Lubricants:
Lubricants prevent ingredients from clumping together and from sticking to the tablet punches
or capsule filling machine. Lubricants also ensure that tablet formation and ejection can occur
with low friction between the solid and die wall.
Common minerals like talc or silica, and fats, e.g. vegetable stearin, magnesium stearate or
stearic acid are the most frequently used lubricants in tablets or hard gelatin capsules.
Sweeteners:
Sweeteners are added to make the ingredients more palatable, especially in chewable tablets
such as antacid or liquids like cough syrup. Therefore, tooth decay is sometimes associated
with cough syrup abuse. Sugar can be used to disguise unpleasant tastes or smells.
Tablet Production
In tablet production there are several steps involved which are following:
➢ Dispensing
➢ Weighing and dry mixing
➢ Wet mixing
➢ Dry mixing
➢ Final drying
➢ Lubrication
➢ Coating (if needed)
➢ Compression
➢ Secondary packaging
Granulation Unit
Granulation is a mechanical process used to change the physical properties of a powder or
powder blend. Flow characteristics, density, and particle size are the primary parameters
influenced by this process.Granulation processes are employed when the raw material powder
or blend exhibits behavior properties that hinder other manufacturing processes. All the
materials are received from the dispensing unit and granulation is performed. For suitable
granulation, it is required to have 30-40% powder and 60-70% granules and also 1-5% moisture
in compressing particles.
Purposes Of Granulation
1. To produce tablets of appropriate size.
2. To prevent segregation of the constituents in the powder mix.
3. To improve the flow properties of the powder mix.
4. To improve compression nature of powder.
27
Types of granules
Two types of granules are produced in the four-granulation units of the industry, which include;
• Granules with active ingredient/s
• Placebo granules without any active ingredient/s for moisture sensitive active/s or
drug/s
Wet granulation:
Wet granulation is a process of using a liquid binder or adhesive to the powder mixture. The
amount of liquid can be properly managed, and over wetting will cause the granules to be too
hard and under wetting will cause them to be too soft and friable. Aqueous solutions have the
advantage of being safer to deal with than solvents.
28
Dry granulation
Dry granulation is the process of forming particles—i.e., granulates or granules—from dry
powder or powder blend without adding liquid to aid in the process. It serves as an established
manufacturing process in the chemical, life science, and pharmaceutical industries, playing a
key role in preparing powdered material for further processing.
Dry granulation equipment offers a wide range of pressure and roll types to attain proper
densification. However, the process may require repeated compaction steps to attain the proper
granule end point.
Slugging or pre-compression
Lubrication
29
Machineries Used During Granulation
New Machine
NO. NAME OF MACHINARY COMPANY NAME
1. RAPID MIXER GRANULATOR EAST, MUMBAI
3. FLUID BED DRIER SHIMADZU, JAPAN
4. WET GRANULATOR YENCHEN MACHINERY CO.LTD,TAIWAN
5. SIFTER YENCHEN MACHINERY CO.LTD,TAIWAN
6. V-CONE BLENDER YENCHEN MACHINERY CO.LTD,TAIWAN
Tablet Compression
Tablets are made by compressing a formulation containing a drug or drugs with excipients on
stamping machines called Tablet Presses or Tablet compression machine.
30
Flow Chart of Tablet Compression
Tablet Coating
Coated tablets are tablets that have one or more layers of a mixture of various substances, such
as natural or synthetic resins, gums, gelatin, inactive and insoluble fillers, sugars, plasticizers,
polyols, waxes, coloring matter approved by the competent authority, and, in some cases,
flavoring and active substances. Coating substances are typically applied as a solution or
31
suspension in conditions that allow the vehicle to evaporate. Film-coated tablets are those that
have a very thin polymeric coating applied.
Coated tablets have a smooth surface that is often colored and polished. A broken section, when
examined under a lens, reveals a core surrounded by one or more continuous layers of a
different texture.
Classification of Coating:
Mainly three types of coating are performed in the solid section. They are as follows:
1) Sugar coating
2) Enteric coating
3) Film coating
Film Coating:
A film coating is a thin polymer-based coat that is typically sprayed onto
solid pharmaceutical dosage forms, such as tablets, capsules, pellets or granules. Film coating
can impact both its appearance and its pharmacokinetics making it an essential process in
making the final drug product.
32
Film coatings are the most common form of drug coating and are generally applied in orally-
administered pharmaceuticals. The motivation for applying film coatings to dosage forms
range from cosmetic considerations (colour, gloss and branding), improving the shelf life by
providing a protective barrier between the drug and the surrounding environment, and making
the dosage form easier to swallow. These types of film coatings are known as non-functional
film coatings. They may also be used to delay or augment the delivery and uptake of
medications or delay release and uptake until the medication passes through the stomach. These
types of film coatings are known as functional film coatings.
Process Principles:
A very even application of the coating material is an important feature of the coating process.
Coatings must be dense and without mechanical damage and cracks. Film coating is an
effective process for the application of protective films for manipulating the product
characteristics. Glatt offers various technical solutions for coating different particles and
tablets:
1. Fluid Bed Coating (Top Spray Coating, Bottom Spray Coating, Rotor Coating)
2. Drum Coating
3. Spouted Bed Technology
4. In each case, the coating fluid is sprayed onto the solid material, which is presented to
it. The introduction of the process air evaporates the fluid and dries the film coating.
Small droplets and a low viscosity ensure a uniform distribution.
Enteric Coating:
An oral dosage form in which a tablet is coated with a material to prevent or minimize
dissolution in the stomach but allow dissolution in the small intestine. This type of formulation
either protects the stomach from a potentially irritating drug (e.g., aspirin) or protects the drug
(e.g., erythromycin) from partial degradation in the acidic environment of the stomach
erythromycin) from partial degradation in the acidic environment of the stomach.
33
Instruments / Apparatus Used in Tablet Coating
There are various types of sophisticated instruments are used for the purpose of tablet coating.
The instruments are:
➢ Coating Machine (FD&C Equipment Pvt.Ltd.), Karachi
Coating Procedure
1. Preparation of coating suspension:
Take purified water in a vessel.
↓
Add the ready coating materials carefully to the region of vortex
↓
Stir the dispersion for 45 minutes.
↓
Filter through 60 mesh size(if necessary)
↓
Add extra purified water for good dispersion (if necessary)
2. Coating process:
Coating suspension (Aqueous)
↓
Tablets into coating pan
↓
Warm up the core tablets for 10 minutes at 35-40°C
↓
Set the required inlet (60-70°C) and outlet(45-55°C) temperature.
↓
Start the coating pan
↓
Set the RPM of coating pan within 2-3
↓
Set the RPM of peristaltic pump within 8-12
↓
34
• Pump speed
• Pan Rotation
• Bed Distance
• Negative Pressure
• Inlet Air Temperature
• Outlet Air Temperature
• Atomizing Air Pressure
• Fluid Return Volume
• Nozzle Distance from the Tablet Bed.
COMMON PROBLEMS ASSOCIATED WITH TABLET COATING:
Logo Bridging
Cause:
1. Surface characteristics of the product being coated
2. Inadequate adhesion of film coating
3. Inadequate design of logo (e.g. too detail/fine logo)
Remedy:
1. Modify core formulation to include more hydrophilic ingredients
2. Increase core porosity
3. Using formulation with increased adhesion property.
4. Increase area within the debossing and modified angles.
Core Erosion
Cause:
1. Inherent softness or high friability of core.
2. Excessive pan speed in coating process.
3. Spray rate too low.
4. High sensitivity of core to moisture as coating is applied.
Remedy:
1. Increase mechanical strength of core.
2. Decrease pan speed.
3. Increase spray rate.
35
Edge chipping/erosion:
Cause:
1. Low mechanical strength of coating
2. Excessive pan speed
3. Low solid content in coating liquid
4. Low spray rate
5. Sharp edges on tablets
6. Worn tablet punches
Remedy:
1. Using formulation with increased mechanical strength
2. Decreased pan speed
3. Increase solid content in coating liquid
4. Decrease spray rate
5. Use modified punch design
Picking/sticking:
Cause:
1. Spray rate too high
2. Inadequate drying condition
3. Pan speed too low
4. Inadequate atomization of coating liquid
5. Poor distribution of coating liquid
Remedy:
1. Decrease spray rate
2. Increase drying condition
3. Increase pan speed
4. Increase atomizing air pressure/volume
Cracking:
36
Cause:
1. Low mechanical strength of coating, exacerbated by inadequate plasticization,
excessive pigmentation.
2. Core has significantly different thermal expansion characteristics than coating.
3. Extended strain relaxation of core after compaction.
Remedy:
1. Selecting formulation with increased mechanical strength and elasticity properties.
2. Avoid use of mineral type fillers (e.g. CaCO3, CaSO4, MgCO3 etc.)
3. Extend holding period of tablets prior to submitting them to coating process.
Peeling:
Cause:
1. Low mechanical strength of coating
2. Poor adhesion of coating to tablet surface
Remedy:
1. Using ingredients of improved mechanical strength.
2. Using ingredients with improved adhesion properties.
Orange peel/roughness:
Cause:
1. Viscosity of coating liquid is too high
2. Poor atomization of coating liquid
3. Excessive drying condition
4. Over wetting (causing coating too rub)
Remedy:
1. Decrease solid content of coating liquid
2. Increase atomizing air pressure/volume
3. Decrease inlet air temperature/flow rate
4. Decrease spray rate
Twinning:
37
Cause:
1. Spray rate too high
2. Pan speed too low
3. Inappropriate tablet shape
Remedy:
1. Decrease spray rate
2. Increase atomizing efficiency
3. Increase pan speed
4. Select new tablet shape that decrease chances of flat surfaces coming into contact
during application of coating liquid. (e.g. avoid capsule shape tablet with thick side
wall)
Tablet-to-tablet color variation
Cause:
1. Too little coating applied
2. Inadequate mixing of tablet during coating
3. Poor opacity (or hiding power)
4. Solid content of coating liquid too high
5. Insufficient number of spray gun
Remedy:
1. Increase quantity of coating applied
2. Increase pan speed/increase improve baffle system
3. Reformulate coating with respect to colored ingredients or use an opacified white pre-
coat.
4. Decrease solid contents of coating liquid.
5. Increase number of spray gun.
Catering
It is defect of film coating whereby volcanic-like craters appears exposing the tablet surface.
Reason:
The coating solution penetrates the surface of the tablet, often at the crown where the surface
is more porous, causing localized disintegration of the core and disruption of the coating.
38
Pitting
It is defecting whereby pits occur in the surface of a tablet core without any visible disruption
of the film coating.
Reason
Temperature of the tablet core is greater than the melting point of the materials used in the
tablet formulation.
Reason:
It is due to collection on the surface of low molecular weight ingredients included in the
coating formulation. In most circumstances the ingredient will be plasticizer.
Sr.
CAUSE REMEDY
No.
High concentration and low
Decrease plasticizer concentration and increase
1. molecular weight of plasticizer.
molecular weight of plasticizer.
Blushing
It is defect best described as whitish specks or haziness in the film.
Reason:
39
The Cause & Remedies of Blushing:
Sl. No. CAUSES REMEDIES
1. High coating temperature Decrease the drying air
temperature
2. Use of sorbitol in formulation which causes Avoid use of sorbitol with
largest fall in the thermal gelation Hydroxy Propyl Cellulose,
temperature of the Hydroxy Propyl Hydroxy Propyl Methyl Cellulose,
Cellulose, Hydroxy Propyl Methyl Methyl Cellulose and Cellulose
Cellulose, Methyl Cellulose and Cellulose ethers.
ethers.
Infilling
It is defect that renders the intagliations indistinctness.
Reason:
Inability of foam, formed by air spraying of a polymer solution, to break. The foam droplets
on the surface of the tablet breakdown readily due to attrition but the intagliations form a
protected area allowing the foam to accumulate and “set”. Once the foam has accumulated to
a level approaching the outer contour of the tablet surface, normal attrition can occur allowing
the structure to be covered with a continuous film.
Reason:
40
• Change atomizing air pressure.
• Change inlet air temperature/air flow.
During our training we have observed the manufacturing of the following tablets:
• ESOCON MUPS
• R-Pil
In process quality control (IPC) of Tablet:
The in process control is made during the course of manufacture of tablet which aims to ensure
that products will comply with specification. Thus, quality is built into the product in
BIOPHARMA Limited; the following parameters are performed for in process checks:
Process In-process checks
Dispensing Weighing & recording
Mixing Time & Speed
Granulation Uniformity of content, time and speed
Drying Temperature (inlet & outlet) pressure, moisture content
Lubrication Uniformity of content
Compression Machine speed, Compression process, thickness, hardness,
friability, appearance, avg. and uniformity of weight, DT
of tablets
Coating Temperature, moisture, speed, time uniformity,
appearance, DT
Tablet Packaging
41
The blister package is formed by heat softening sheet of thermo plastic resin and vacuum
drawing the softened sheet of plastic into a contourd mold, Aluminum foil and PVC
blister are used in this packaging.
B. Strip Package
A strip package is formed by feeding two webs of a heat-sealable flexible film through
either a heated crimping roller or a reciprocating platen. Aluminum foils are used in this
packaging.
Following Packaging Machines are used in BPL
Blister machine-1
Company : Hoonga-A corporation
Source : Korea
Blister machine-2 (Automatic)
Company : Hoonga-A corporation
Source : Korea
Liquid:
The oral use of liquid pharmaceuticals has generally been justified by the ease of
administration to those who have difficulty swallowing solid dosage forms. A drug
administered in solution is immediately available for absorption and, in most cases, is
absorbed more quickly and efficiently than the same amount administered in tablet or capsule
form.
Advantages of Liquid Dosage Form
1. They are homogenous; there the medicament is uniformly distributed throughout the liquid.
42
2. The doses can be easily adjusted according to the need of the patient.
3. They can be easily measured with the household measured.
4. They are more quickly effective than tablets or capsule because they are already in the
solution form and absorption starts quickly.
5. They can be easily colored, flavored or sweetened.
6. Children or patient who cannot swallow tablets or capsule can easily ingest solutions.
2.Suspension
43
Production of Syrup:
Manufacturing Vessel
(Tanner stainless steel
Fabricating vessel)
Homogenizer
Filtration
Storage vessel
Bottle filling
Sealing
Labeling
Packaging
Production of Suspension:
Mixing active ingredient & excipients in manufacturingVessel
(Tanner stainless steel fabricating vessel)
Homogenizer
Stirring
Storage vessel
Bottle filling
Sealing
Labeling
Packaging
44
During our training period, we have observed manufacturing of-
♦ LACTU syrup
Filling of bottles
45
Packaging Sealing, Exp date, MRP, Batch no and other information on the packaging
material etc.
Machineries Used in Filling & Packaging Unit
A cream is a topical preparation usually for application to the skin. Creams for application to
mucus membranes such as those of the rectum or vagina are also used. Creams may be
considered pharmaceutical products as even cosmetic creams are based on techniques
developed by pharmacy and unmedicated creams are highly used in a variety of skin conditions
(dermatoses).Creams are semi-solid emulsions, that is mixtures of oil and water. They are
divided into two types: oil-in-water (O/W) creams which are composed of small droplets of oil
dispersed in a continuous aqueous phase, and water-in-oil (W/O) creams which are composed
of small droplets of water dispersed in a continuous oily phase. Savlon A/C cream
manufacturing process are given below.
46
Materials Used:
1. Strong cetrimide BP
2. Chlorohexidine HCL BP
3. Cetostearyl alcohol BP
4. Liquid paraffin BP
5. Antiseptic perfume compossedPh.grade
6. Purified water
47
Dry syrup
Dry Syrup Section
Dry syrup is the preparation that is formulated as dry powder but administered orally as
liquid dosage form. They are prone to hydrolysis during extended exposure of moisture. They
are to be reformulated by mixing with certain amount of boiled water and should be use up
within certain periods (5 days at normal temperature).
Physical plant design:
It is divided into two areas-
48
Steps of Dry Syrup Preparation:
Weighing
Mixing
Sieving
Cone blending
Mixing
Q.C Analysis
Finished product
Capsule
49
Capsule Section
Capsules are the solid unit dosage form of medicament in which the drug(s) is enclosed in a
practically tasteless, hard or soft soluble container or shell made up of a suitable form of gelatin.
Gelatin shells are supplied in a number of sizes. The number varies from 000 to 5, the former
being the largest and later the smallest. The exact amount of a medicament which can be filled
in a particular size of capsule shell depends upon density of the material to be filled in.
Generally the capacity varies from 600mg to 30mg.
Advantages
• Capsules are tasteless, odorless and can be easily administered.
• Attractive in appearance.
• The drugs having unpleasant odor and taste are enclosed in a tasteless shell.
• They can be filled quickly and conveniently therefore the physician can change the dose
and combination of drugs to suit the individual patient. This is an advantage over
tablets.
• Flexibility in onset and duration of action also contribute to the suitability of the capsule
as a pharmaceutical dosage form.
• Ease of formulation.
• Limited potential for incompatibilities.
• Good stability.
• Easy to swallow.
• They are economical.
• They are easy to handle and carry.
Disadvantages
• Capsules are not usually used for the administration of extremely soluble materials such as
potassium chloride or ammonium chloride.
• Capsules should not be used for highly effervescent or deliquescent materials. Effervescent
materials may cause the capsule to soften.
• Deliquescent powders may dry the capsule shell to excessive brittleness.
• The concentrated solutions which require previous dilution are unsuitable for capsules
because if administered as such lead to irritation in the stomach.
50
• Manual- This type of filling process is used to fill powder materials or the materials which
have poor flow property.
• Auto- Mainly pellets which have good flow property are used to fill by this process.
In this machine the capsule pouring system is automatic, but the system of filling (powder,
pellets) or locking is manual.
Name of the company: Pharmaceutical and allied machinery company privet limited.
51
Fig. Hand Operated Capsule Filling Machine
52
Quality Control Department
Assigned person,
Farooque Ahmed Bhuiyan, Sr. Manager, QC
Aslam Ali, Asst.Manager, Microbiology
Ezazul Haque, Exe. Microbiology
53
Quality Control Unit
It is the part of good manufacturing practice, which is concerned with sampling, specification
and testing as well as the organization and documentation and released procedures. It ensures
the necessary and relevant tests that are necessary to determine whether the products will be
released or not for use, the raw materials can be used or not until their quality has been judged
to be satisfactory.
Biopharma Lab Ltd primary missions are to contribute to better health and quality of life for
people.
Quality control is responsible for the day-to-day control of quality in the company, who asses
and assure the testing of raw materials, in process testing and the finished product.
Diagrammatic representation of present QC activities.
Raw materials
analysis
Stability Finished
product
In process Microbiological
testing QC
testing
54
• Label control.
The objectives of quality assurance are achieved when processes have been defined which,
when followed, will yield a product that complies with its specification and when the finished
product.
55
In-Process Control
Quality control section always performs in-process check. The In-process Control (IPC) is the
checks made during the course of manufacture which aims to ensure that product will comply
with specifications. This type of checks carried out during the manufacturing process.
In-process checks done by Biopharma Lab. Ltd. is given below
Tablet
Serial Process In-process checks
No.
01 Dispensing Weighing and Recording
Room condition (Temp. & RH).
02 Granulation Content Homogeneity of the granules
03 Drying Loss on Drying (LOD)
04 Compression Room condition (Temp. & RH)
Appearance of tablets (Sticking, Capping,
Lamination, chipping, )
Average weight of the tablet
Compression pressure
Hardness, Thickness & Diameter of tablets
Friability of tablets
Disintegration time
06 Coating Visual Inspection of appearance
07 Strip / Blister strip Leak Test
operation
Capsule
56
Liquid Processing, Filling & Packaging
Serial No. Process In-process checks
01 Bulk Appearance, Odor and color
PH
02 Filling line Fill volume / Fill weight
Cap Sealing
Appearance of filled liquid
Dry Syrup
Serial No. Process In-process checks
Packaging Materials
Serial Process In-process checks
No.
01 Label Grain direction: the label is kept on water in a pot
and observed that it is properly rolled or not. After
awhile it will be opened to indicate that it is
passed.
Printing test (expires date, manufacturing date,
batch no)
The color & size are also checked against a
standard.
02 Cartoon The color & text are compared with an approved
standard.
Print over lapping check.
Proper locking check.
57
Finished Product Control
SL. Dosage Form Checks
No.
01 Leak test,
Tablet Packing Size,
Printing test (Expires Date, Manufacturing Date and
Batch Number.)
02 Leak test,
Capsule Packing Size,
Printing test (Expires Date, Manufacturing Date and
Batch Number.)
03 Container test,
Vitamin Aluminum sealing test,
Cap sealing test,
Printing test (Expires Date, Manufacturing Date and
Batch Number.)
03 Bottle test,
Liquid (Syrup, Microbial Contamination test.
Suspension) Cap sealing test,
Printing test (Expires Date, Manufacturing Date and
Batch Number.)
04 Bottle test,
Dry Syrup Cap sealing test,
(Syrup, Printing test (Expires Date, Manufacturing Date and
Suspension) Batch Number.),
05 Cap sealing test,
Ointment, Printing test (Expires Date, Manufacturing Date and
Cream Batch Number.),
06 Sterile Impurities test under light.
Printing test (Expires Date, Manufacturing Date and
Batch Number.),
Packaging materials analysis includes the inspection of all kinds of packaging materials such
as ampoule, bottle, rubber, seals etc.
Parameters that are checking for different packaging materials are given bellow.
Bottle:
➢ Appearance.
➢ Color.
➢ Ave. Weight.
➢ Neck screw cap.
➢ Mouth diameter.
➢ Body diameter.
➢ Height.
58
➢ External and internal diameter.
Rubber closure:
➢ Chemical test for acidity/alkalinity.
➢ Fragmentation test.
➢ Plug diameter.
➢ Flung diameter.
➢ Absorption test by UV-spectrometer.
➢ Total height.
Test for Foils:
➢ Appearance.
➢ Thickness.
➢ Ave. weight.
➢ Text.
➢ Lamination.
➢ Width.
Labels:
➢ Printing.
➢ Type of paper.
➢ Size.
➢ Breadth.
➢ Length.
➢ Thickness.
➢ Color.
➢ Appearance.
Inserts:
➢ Length.
➢ Text.
➢ Breadth.
➢ Types of paper.
Apparatus Used in Quality Control Unit:
High Performance Liquid Chromatography (HPLC):
59
components in a mixture spend more or less the same time in the mobile phase in order to exit
the column. Monitoring of the column effluent can be carried out with a variety of detectors.
Applications:
Advantages:
60
Supervising
(A representative from the QC department receives
the sample & assign someone to analyze)
Analysis
(The analyst analyses the sample)
Checking
(After the tests, the results are checked)
Final approval
(The QC Manager verifies the result)
Collection
(QA officer collects the results of the sample That was assigned previously)
2. UV spectroscopy:
Mode: UV-1650PC
Source: Shimadzu, Japan
Mechanism of UV spectroscopy:
Prepared sample solution at very
Lower conc. usually several gm or mg level
61
3.FTIR (Fourier Transform Infrared Spectroscopy):
Model: FTIR-8300
Source: Shimadzu, Japan
Mechanism of FTIR:
Produce KBr disc of sample (raw materials)
here very minor amount of sample is used
and it must be free from moisture
Show absorbance
5.Analytical Balance
Model: B 204S, Switzerland
Quantity: 01
6.Microscope
Origin: Germany
7.Flask Shaker
Origin: India
8.pH meter
It is used to determine the pH value.
Origin: United Kingdom
11.Colony counter
Mode: 8301, Origin: Germany
62
12.I.R Humidity Control Chamber
Model: MPRT-U 160/100, Origin: Germany.
13.Refractometer
Origin: Japan
15.Water-bath, boiling
Model: Type-3030, Origin: Germany
16.Autoclave
Origin: China
17.Micrometer
Origin: Japan
Microbiology Unit
63
Microbiology Unit
Microbiology department is the department where various microbiological tests are performed
to kill, free, count or suppress the micro-organism. The tests which can not be performed
chemically go through microbiological test.
Activities
➢ Microbiological analysis of raw materials and finished products.
➢ Bioassay of antibiotics using different methods such as Diffusion method, Turbidity
method.
➢ Regular test of non ionized water, tap water and bulk water.
Various types of tests performed in the Microbiological department of Bio-Pharma Lab. Ltd.
are shown as below:
BIOPHARMA Ltd. Sterilized all of those products by using the following methods.
FILTRATION METHOD
Test for sterility of microorganism by using cellulose membrane filter in the filtration method.
The pore size is 0.22 micron & diameter is 47 mm.
64
The liquid is passed trough the filter paper
No turbidity
Sterility passed
2. To cheek pathogenic microorganism:
To cheek pathogenic microorganism on the basis of various food the following media
are used:
Ordinary media:
e.g.
✓ N B – Nutrient broth.
Indicated media:
e.g. Blood agar
➢ Raw material.
➢ Oral liquid.
➢ Semisolid e.g. cream, ointment etc.
65
Method of Limit Test:
10 gm of raw material or semisolid is mixed up uniformly with 100 ml of water. From
this solution 1 ml of the solution is transferred to a petridish, and then a suitable media
is added for particular organism.
Comments:
We expect that the
1. Microbiology department of Bio Pharma Lab. Ltd. will be extended in future.
2. The space is very small for conducting experiments.
3. The washing room should be separated from the microbiology laboratory.
66
Warehouse & Inventory Control Department
67
Introduction:
The warehouse is an essential part of the pharmaceutical industry. Here the raw materials are
stored in specified condition.
The Warehouse of BIOPHARMA Ltd. is properly organized. Different Tags with different
colors are used to identify the materials easily in the storage area in specific space.
1. Quarantine Area
2. Rejected Materials area
3. Main storage area
1. Quarantine Area:
After receiving of raw materials they are stored first in the quarantine area. After Q.C.
sampling and checking, the approved materials are shifted to the main storage area
and the rejected materials are transferred to the rejected materials area.
Important Functions:
➢ According to monthly program, this department has the responsibility to get
final Q.C. approval for raw materials.
➢ According to plan and recovery maintenance, the raw materials are supplied
to the production area for required batch size.
➢ Specific raw materials are stored in specific mentioned area with proper
documentation. Capsule shells are kept in 150c & aluminum foil in 00c to
250 c.
➢ There is another room in second floor of Orion where various stationary &
gift items are stored.
Packaging Materials:
Packaging materials, e.g. master pack, carton, foil, inner pack, catch covers etc are stored here
with controlling humidity and temperature.
68
Working Procedure of Warehouse:
The raw materials and packaging materials are dispensed according to the requisition sheet of
the production. The total procedure given below-
FIG:
Flow of raw materials from the ware house
69
Vander evaluation by quality assurance.
70
Engineering Department
Assigned person,
Md. Mostafizur Rahman
Sr. Asst. Manager, Engineering
71
Introduction:
Biopharma Lab. Ltd has an independent maintenance department for looking after production
and utility machineries. The responsibilities of maintenance department are to install, maintain,
handle and solve all types of problems such as electrical and mechanical problems. Utility
support is very important for smooth operation of all production machineries.
➢ Preventive maintenance
➢ Breakdown maintenance
➢ Daily checking
Flow Chart of Working Procedure:
72
Water Treatment & Distribution System:
Water is essential for pharmaceutical manufacturing & cleaning purposes.
Water used in pharmaceutical plant is of following kinds
Potable water
De-mineralize (DM) Water.
Water for Injection (WFI)
Potable water:
Water is pulled below ground by a submersible pump. This water is then use as drinking,
washing floor and room and further it is used to produce DM water as well as water for injection
(WFI).
73
Finished Product of Biopharma Ltd.
Introduction:
Every production biased company has a ware house. There are three types of ware house.
Finished product store exist of them. It plays vital role to support SCM (Supply Chain
Management) as well as keeping stock management. F.P store has loyal obligation. So it should
not exist in out side of the plant. It must have been in the plant. But other two stores should be
out side if production has sound logistic support to convey product resources. Through F.P
store SCM is starting to transmit product to end user.
Room arrangement:
1) U-Shape
2) I-Shape
Connection to other department:
-Communicate with-
-Production,
-Commercial Dept.,
-PMD.
74
-VAT Section
-Finance & Accounting Dept.
-Costing Dept.
-Externally related with customs excise and VAT Department of
- Bangladesh Revenue Board.
75
Product of Biopharma
76
SUPRALEX
Cefuroxime BP 250mg capsule
Cefuroxime BP 500mg capsule
Cefuroxime BP powder for suspension 100ml
(125mg /5ml)
BESTCEF
Cefixime USP 200mg capsule
Cefixime USP dry powder for suspension 37.5ml
(100mg /5ml)
Cefixime USP dry powder for suspension 50ml
(100mg /5ml)
MEXTIL
Cefuroxime BP 125 mg tablet
Cefuroxime BP 250 mg tablet
Cefuroxime BP powder for suspension
70ml (125mg /5ml )
77
BIOTRIM
Cotrimoxazole (Sulphamethoxazole BP 400mg &
Trimethoprim BP 80 mg ) tablet
Cotrimoxazole BP dry powder for suspension 60ml
(SMZ 200 mg/ 5ml & TMP 40 mg /5ml)
BIOTRIM DS
Cotrimoxazole double strength
(Sulphamethoxazole BP 800mg & Trimethoprim BP
160 mg ) tablet
EROSA
Erythromycin USP 250 mg film coated tablet
Erythromycin USP 500 mg film coated tablet
Erythromycin USP powder for suspension 100ml
(125mg /5ml)
Erythromycin USP paediatric drops 15ml (100mg /ml
)
Erythromycin USP paediatric drops 30ml (100mg /ml
)
MACZITH
Azithromycin USP 250 mg capsule
Azithromycin USP 500mg film coated tablet
Azithromycin USP dry powder for suspension 15ml
(200mg /5ml)
ANTI-FUNGAL DRUGS
FUNGATA
Fluconazole BP 50 mg capsule
Fluconazole BP 150mg capsule
Fluconazole BP dry powder for suspension 35ml
(50mg /5ml)
Fluconazole BP dry powder for suspension 60 ml
( 50mg /5ml)
ANTI - HISTAMINES
78
BIOCIN
Chlorpheniramine maleate BP 4mg tablet
Chlorpheniramine maleate BP syrup 100ml(5mg/5ml)
LORFAST
Loratadine INN 10mg tablet
Loratadine INN suspension 60ml (5mg/5ml)
ANTI - EMETIC
ESOGUT
Domperidone BP 10 mg film coated tablat
Domperidone BP suspension 30 ml ( 5mg /5ml)
Domperidone BP suspension 60 ml ( 5mg /5ml)
Domperidone BP paediatric drops 15ml (5mg /ml )
Domperidone BP paediatric drops 30ml (5mg /ml )
AVERT
Meclizine HCI USP 50mg tablet
ANTHELMINTICS
AZOLE
Albendazole USP 400mg chewable tablet
Albendazole USP suspension 10ml (200mg/5ml)
BIOTREX
levamisole BP syrup 30ml (40mg/5ml)
BIOCID MH
(Aluminum Hydroxide BP +Magnesium Hydroxide
BP ) suspension 200 ml
79
Suggestion
Production Department:
1. Solid Unit:
• The solid and LCO Departments may be divided from the dispensing area.
• One may be able to move more deliberately.
• This is where antibiotic production can be avoided.
• It might be more preferable for personnel to wear long aprons throughout the
granulation phase.
• In this case, compliance activities could be enhanced.
3. WareHouse:
• It is possible to manage raw material and finished product storage
separately from warehouse 2.
• Space may be enlarged
• Self-life storage room may be separated from warehouse.
• The warehouse may be kept in a more hygienic and salubrious state.
• Products that were damaged were kept in ware house-2 for an extended
period of time. To free up some space, these products might be
eliminated.
• One region's products were found in another.Therefore, this needs to
be considered.
• It is recommended that human and animal health products be stored in
completely distinct locations.
4. Other:
• Each trainer or guest should have an adequate supply of clean
aprons, shoe covers, masks, and hair covers.
80
Conclusion
With the cooperation of the authorities and all the staff, our eight days of training at
BIOPHARMA Ltd. went by extremely quickly, but we still learned a lot and gained a lot of
experience that will be useful for our future practical needs. We were warmly welcomed by the
appropriate authority in each section. They piqued our interest in the pertinent topics and
sparked our curiosity. We are happy with how each and every employee in the factory has
behaved. We therefore feel that we have finished our training with great satisfaction, and we
hope that you feel the same.
We thought the following technical features of BIOPHARMA Ltd. were particularly
commendable:
The BIOPHARMA Ltd. plant in Tongi has an outstanding plant layout. It was undoubtedly a
really well thought out arrangement that maximises space utilisation, is simple to use, and
greatly aids in achieving maximum productivity. Moreover, there is plenty of room to grow
when the time comes. Additionally lovely is the plant section, which has a prayer space of its
own
A pleasant and sympathetic culture boosts a company's production, therefore it's great if the
factory is well-organized and the internal environment is supportive of the employees. There's
always space for improvement, but the meal menu was thought to be excellent and the canteen
is also really attractive.
Biopharma Ltd. is impressive for the variety and high calibre of its products. Additionally, we
were quite pleased with the company's adherence to ISO 9001 standards in terms of GMP
maintenance and thorough documentation of all work performed.
One of Biopharma Limited's most noteworthy accomplishments is their efforts to launch
valuable products at a reduced pricing point.
Finally, we would like to express our gratitude to Almighty Allah, all of the participants, and
ourselves for the successful completion of this training. We also hope that Biopharma Ltd. will
continue to cooperate in order to permit In-plant Training in the future.
The Ends
81